IRCT20220830055834N1RecruitingPhase 1
Clinical trials of a syrup from three medicinal plants with effective index glycyrrhizin index in reducing inflammation, cough, and duration of hospitalization caused by Covid-19
Khoram-Abad University of Medical Sciences0 sites82 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Phase 1
- Status
- Recruiting
- Sponsor
- Enrollment
- 82
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 years to 65 years (—)
- Sex
- All
Inclusion Criteria
- •Age between 18 to 65 years old
- •Proven infection with COVID - 19
- •Ability (mental and physical ) to use the drug syrup
- •Lack of hypersensitivity to the drug and similar compounds.
- •Ability to respond to contact and interview about the effectiveness of the drug.
- •patient must have not be hospitalized in the ICU ward.
Exclusion Criteria
- •Negative criteria for COVID-19 infection
Investigators
Similar Trials
Completed
Phase 3
Evaluation of Malva Sylvestris. formulation on Radiation proctitisIRCT2012101011064N1Vice chancellor for education, faculty of ?Traditional Medicine, Tehran university40
Active, not recruiting
Phase 1
Ratifying dosage and duration for levo-bupivacaine, a local anaesthetic infusion by the caudal-epidural route in infants 3-6 months.EUCTR2015-000393-34-GBCentral Manchester University Hospitals NHS Foundation Trust10
Active, not recruiting
Not Applicable
study of effective pharmacological cardioversion of paroxysmal atrial fibrillation with flecainide vs vernakalantAtrial fibrillation paroxysmalMedDRA version: 17.1Level: LLTClassification code 10003661Term: Atrial fibrillation paroxysmalSystem Organ Class: 100000004849EUCTR2014-003641-95-ESicasio Pérez Castellano
Recruiting
Phase 2
A clinical trial to evaluate the effect of an Ayurvedic medicine, varyadi kashaya in patients with raised blood levels of uric acid.CTRI/2023/03/050452INSTITUTE OF POST GRADUATE AYURVEDIC EDUCATION AND RESEARCH AT S.V.S.P.
Not yet recruiting
Phase 3
Treatment of Bronchial Asthma(difficulty in breathing) with Unani medicine Habb-e-BanafshaCTRI/2021/05/033781Central Council for Research in Unani Medicine CCRUM New Delhi